PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Shu Xu

School of Basic Medical Sciences and Clinical Pharmacy, China Pharmaceutical University, Nanjing, People's Republic of China.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 3, 2026 · JOURNAL ARTICLE

Intranasal drop of multiplex RNA therapy for SARS-CoV-2 infections: baicalein-enhanced FEN1 nuclease cleaving as a virus buster.

Emerging Microbes & Infections

Early-stage in vivo study in mice using a novel intranasal nanomedicine formulation with a surrogate endpoint (viral load reduction), lacking control group details, clinical outcomes, and adequate sample size reporting.

PreliminaryNucleic-acid Targeted Therapy Peiliang Wang Yuan Gao

Study details

DesignIn vivo preclinical study in mice

InterventionIntranasal nanomedicine formulation compris…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support